• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
XCUR

XCUR

Exicure, Inc.

NASDAQHealthcareBiotechnologyUS

USD3.16

+0.05 (+1.61%)

Rating:C-

Company Profile

CEO

Jungsoo Kim

IPO Date

2018-05-22

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.16

Prev. Close

$3.11

Day Low

$3.02

Day High

$3.16

52W Low

$2.63

52W High

$10.80

Market Cap

$0.02B

Volume

0.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

8

Avg Positive

16.6%

Avg Negative

2.5%

Avg Neutral

80.5%

News Feed

Exicure Announces Appointment of Brian C. Bock as Chief Financial Officer (CFO)

Business Wire·5/13/2021·↓ negative

Exicure, Inc. (XCUR) Reports Q4 Loss, Misses Revenue Estimates

Zacks Investment Research·3/11/2021·↑ positive

Spherical Nucleic Acid Technology Shows Promising Results in Phase 0 Trial in Patients With Glioblastoma at Northwestern University

Business Wire·3/11/2021
·↑ positive

Exicure, Inc. Reports Full Year 2020 Financial Results and Corporate Progress

Business Wire·3/11/2021·↑ positive

Exicure Announces Appointments of Elizabeth Garofalo, M.D., and Andrew Sassine to Its Board of Directors

Business Wire·3/9/2021·↑ positive

Exicure, Inc. (XCUR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Zacks Investment Research·3/2/2021·↑ positive

Exicure Announces Presentation at 2021 H.C. Wainwright Global Life Sciences Conference

Business Wire·2/23/2021·↑ positive

Exicure Announces Webcast of Presentation at 2021 HC Wainwright BIOCONNECT Conference

Business Wire·12/29/2020·↑ positive